Expanesthetics is the global leader in inhaled anesthetic innovation. We are using screening technology based on groundbreaking science to search for new inhaled anesthetics with side effect profiles superior to today’s drugs. So far, our pre-clinical research has revealed compounds that may turn out to have compelling characteristics such as cardiovascular stability, kinetics comparable to xenon, and unique physical properties. We believe that finding anesthetics that lack the undesirable effects of today’s agents (or anesthetics that have exciting new benefits such as analgesia) could save billions in healthcare costs and expand the availability of surgery to some of the 5 billion people who lack it today.
Since our founding in 2012, we’ve continually heard anesthesiologists affirm the desire for a new, improved inhaled anesthetic. In fact, anesthesiologists form our primary base of investors. Come visit us in Booth #1813 to learn more.